Mortality-rate. complications, contra-indications
In the hands of the experienced, the mortality-rate of the two treatments is equally low. It was 1 per cent among the first 700 insulin patients, and 0.5 per cent among the first 600 cardiazol patients, but with accumulating experience it fell to 0.4 per cent among 500 patients recently treated in Switzerland. There is less likelihood of emergencies arising with cardiazol than with insulin hypoglycemia, where laryngeal spasm, failure to awake from corna, or 
